Literature DB >> 19409982

Metabolic syndrome and oxidative stress.

Katsuyuki Ando1, Toshiro Fujita.   

Abstract

Metabolic syndrome is an obesity-associated collection of disorders, each of which contributes to cardiovascular risk. Metabolic syndrome is also associated with overproduction of reactive oxygen species (ROS). ROS contribute to the interrelationship between metabolic syndrome and salt-sensitive hypertension, which are both caused by obesity and excess salt consumption and are major threats to health in developed countries. ROS can induce insulin resistance, which is indispensable for the progression of metabolic syndrome, and salt-sensitive hypertension stimulates ROS production, thereby promoting the development of metabolic syndrome. Moreover, ROS activate mineralocorticoid receptors (MRs) and the sympathetic nervous system, which can contribute to the development of metabolic syndrome and salt-sensitive hypertension. Salt-induced progression of cardiovascular disease (CVD) is also accelerated in animal models with metabolic syndrome, probably owing to further stimulation of ROS overproduction and subsequent ROS-induced MR activation and sympathetic excitation. Therefore, ROS contribute to the progression of the metabolic syndrome itself and to the CVD accompanying it, particularly in conjunction with excessive salt consumption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409982     DOI: 10.1016/j.freeradbiomed.2009.04.030

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  41 in total

1.  Phenolic composition, antioxidant and enzyme inhibitory activities of Eryngium bornmuelleri leaf.

Authors:  Abdullah Dalar; Musa Türker; Dimitrios Zabaras; Izabela Konczak
Journal:  Plant Foods Hum Nutr       Date:  2014-03       Impact factor: 3.921

2.  Comment on "The effect of septoplasty surgery on serum oxidative stress levels".

Authors:  Hyun Jin Min; Kyung Soo Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-15       Impact factor: 2.503

3.  High-dose consumption of NaCl resulted in severe degradation of lipoproteins associated with hyperlipidemia, hyperglycemia, and infertility via impairment of testicular spermatogenesis.

Authors:  Eun-Young Lee; Kyung-Hyun Cho
Journal:  Toxicol Res (Camb)       Date:  2016-01-08       Impact factor: 3.524

4.  Monomethylarsonous acid, but not inorganic arsenic, is a mitochondria-specific toxicant in vascular smooth muscle cells.

Authors:  Clare Pace; Tania Das Banerjee; Barrett Welch; Roxana Khalili; Ruben K Dagda; Jeff Angermann
Journal:  Toxicol In Vitro       Date:  2016-06-17       Impact factor: 3.500

Review 5.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

6.  4-Hydroxyl-oxoisoaporphine, one small molecule as theranostic agent for simultaneous fluorescence imaging and photodynamic therapy as type II photosensitizer.

Authors:  Qi Xu; Yunfan Ji; Meijun Chen; Xusheng Shao
Journal:  Photochem Photobiol Sci       Date:  2021-03-20       Impact factor: 3.982

7.  Inflammation and reactive oxygen species in cardiovascular disease.

Authors:  Nannan Zhang; Bradley T Andresen; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-12-26

8.  A Drosophila model for the screening of bioavailable NADPH oxidase inhibitors and antioxidants.

Authors:  Nguyen Thi Tu Anh; Maiko Nishitani; Shigeharu Harada; Masamitsu Yamaguchi; Kaeko Kamei
Journal:  Mol Cell Biochem       Date:  2011-02-11       Impact factor: 3.396

Review 9.  Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Authors:  Eric E Essick; Flora Sam
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

Review 10.  Insulin signaling and life span.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg; Gian Paolo Fadini
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.